Sciatica Treatment Market: Current Analysis and Forecast (2021-2027)

Sciatica Treatment Market: Current Analysis and Forecast (2021-2027)

The sciatica treatment market is expected to register a CAGR of approx. 8% over the period of 2022-2028. Sciatica is a lower back pain that originates in the sciatic nerve and travels down one or both legs. The sciatic nerve is the largest in the human body. The sciatic nerve begins at the lumbar spinal cord nerve origins in the lower back and travels through the buttocks to direct nerve terminals below the lower limb. The disease develops when a bone spur on the spine compresses a nerve. This causes stiffness and pain in the surrounding area. The most common symptom of sciatica is mild to severe pain that runs from the lower back to the buttocks. Furthermore, the patient may experience a burning sensation, which can sometimes feel like a jolt. The growing demand for sciatica treatment can be attributed to the increasing incidence of sciatica patients suffering from back pain-related problems. Increasing healthcare demands coupled with robust investments in research and development of advanced medication for the treatment of sciatica patients to provide instant pain relief is boosting the market growth. For instance, In March 2022, Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., announced final results for SP-102 (SEMDEXA) efficacy and safety from its pivotal Phase III clinical trial program for Sciatica pain management. SP-102 (SEMDEXA) demonstrated pain relief that continued through 12 weeks. Owing to the glaring statistics rise in the number of people suffering from back pain due to compression in nerves need instance pain management for which new innovations and clinical trials are going across the globe are leading to the growing demand for sciatica treatment and would contribute to the growth of the market in the forthcoming period as well. Furthermore, the sciatica treatment market is anticipated to grow on account of the increasing injury, infections in or around the lumbar spine, internal bleeding, muscle, tumors, and irritation of the nerve from adjacent bone which cause irritation in the sciatica nerve. However, some of the restraints in the market including the complications in sciatic surgery such as the risk of bleeding, infections, etc. are impeding the growth of this market all over the world.

• Based on the type, the sciatica treatment market is segmented into acute sciatica, chronic sciatica, and others. The acute sciatica segment accounted for a significant market share and it is estimated that it will grow rapidly during the projected timeframe. Acute sciatica occurs for a shorter duration of time due to compression in the sciatica nerve compression. It generally occurs in the young generation or working population.
• Based on therapy, the market is fragmented into physical therapy, chiropractic therapy, stimulation devices, and others. The physical therapy segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. It incorporates a combination of strengthening, stretching, and aerobic conditioning and is a central component of almost any sciatica treatment plan.
• Based on treatment, the market is fragmented into medication and surgery. the medication segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. Medication helps in maximum cases of sciatica for recovering fast and they are safer than surgery.
• Based on the drug, the market is fragmented into anesthetics, pain killers, muscle relaxants, antidepressants, steroids, and others. the pain killers segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. Painkillers are usually taken in order to reduce the pain and allow the patient to participate in physical therapy.
• Based on end-users, the market is segmented into hospitals, home care, specialty clinics, and others. The home care segment accounted for a significant market share and it is estimated that it will grow rapidly during the projected timeframe. Home care is the main and important component in this sciatic treatment for patients to get rest from work and relax the lower body for faster recovery.
• For a better understanding of the market adoption of sciatica treatment, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the sciatica treatment industry owing to the awareness among the people about the sciatica disease and the availability of advanced medications.
• Some of the major players operating in Endo Pharmaceuticals Inc, AstraZeneca, Novartis AG, Teva Pharmaceutical Industries Ltd, Johnson & Johnson Services Inc, Omega Laser Systems Ltd., Pfizer Inc, Sanofi, Aurobindo Pharmaceutical, Glenmark Pharmaceutical Ltd. among others. Several M&A’s along with partnerships have been undertaken by these players to develop new supplements.